Rollover Study in Participants With Metastatic Solid Tumors Benefiting From Therapy With Sacituzumab Govitecan-hziy
Clinical trial NCT04319198 · COMPLETED
Trial details
- NCT number
- NCT04319198
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-04
- Primary completion
- 2024-10-18
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.